首页 > 最新文献

The Egyptian Journal of Medical Microbiology最新文献

英文 中文
Comparative Evaluation of Colistin Susceptibility Testing Using Agar Dilution and Broth Microdilution in Multidrug-resistant and Extensively Drug-resistant Gram-Negative Isolates 多重耐药和广泛耐药革兰氏阴性分离株中琼脂稀释法和微量肉汤稀释法黏菌素药敏试验的比较评价
Pub Date : 2023-07-01 DOI: 10.21608/ejmm.2023.310119
Abeer K. Abu-El-Azayem, R. Dwedar, N. Nashaat, R. Shash
ABSTRACT
摘要
{"title":"Comparative Evaluation of Colistin Susceptibility Testing Using Agar Dilution and Broth Microdilution in Multidrug-resistant and Extensively Drug-resistant Gram-Negative Isolates","authors":"Abeer K. Abu-El-Azayem, R. Dwedar, N. Nashaat, R. Shash","doi":"10.21608/ejmm.2023.310119","DOIUrl":"https://doi.org/10.21608/ejmm.2023.310119","url":null,"abstract":"ABSTRACT","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81795008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Detection of Human Norovirus among Children (0-5 Years) Attending Selected Hospitals in Kano Metropolis, Kano State, Nigeria 在尼日利亚卡诺州卡诺大都会选定医院就诊的0-5岁儿童中诺瓦克病毒的分子检测
Pub Date : 2023-07-01 DOI: 10.21608/ejmm.2023.307443
Nusaiba Kabir Abubakar, Taysir Abdelrahman, Auwal Idris Kabuga, Lawal Dahiru Rogo
ABSTRACT
摘要
{"title":"Molecular Detection of Human Norovirus among Children (0-5 Years) Attending Selected Hospitals in Kano Metropolis, Kano State, Nigeria","authors":"Nusaiba Kabir Abubakar, Taysir Abdelrahman, Auwal Idris Kabuga, Lawal Dahiru Rogo","doi":"10.21608/ejmm.2023.307443","DOIUrl":"https://doi.org/10.21608/ejmm.2023.307443","url":null,"abstract":"ABSTRACT","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"46 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88000131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usage of Trifluoperazine Hydrochloride as Colorimetric Reagent for Quantitative Assay of Sulfamethoxazole Drug and Applications on Different Some Infection Treatment Preparations 盐酸三氟哌嗪作比色剂定量测定磺胺甲恶唑及在不同感染治疗制剂中的应用
Pub Date : 2023-04-08 DOI: 10.21608/ejm.2023.181202.1223
Haydar S.M. AL-Hujaimi, Mohauman AL- Rufaie, Zahraa M.M. Alrufaie
{"title":"Usage of Trifluoperazine Hydrochloride as Colorimetric Reagent for Quantitative Assay of Sulfamethoxazole Drug and Applications on Different Some Infection Treatment Preparations","authors":"Haydar S.M. AL-Hujaimi, Mohauman AL- Rufaie, Zahraa M.M. Alrufaie","doi":"10.21608/ejm.2023.181202.1223","DOIUrl":"https://doi.org/10.21608/ejm.2023.181202.1223","url":null,"abstract":"","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"137 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76186596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Random SARS-CoV-2 antibody screening in Egypt during the COVID-19 third wave 第三波疫情期间埃及SARS-CoV-2随机抗体筛查
Pub Date : 2023-04-01 DOI: 10.21608/ejmm.2023.291146
M. Gaafar, Mariam Balah, Hebatallah A. Kassem, H. Sabry, Reem ElMessiery, N. Soliman
{"title":"Random SARS-CoV-2 antibody screening in Egypt during the COVID-19 third wave","authors":"M. Gaafar, Mariam Balah, Hebatallah A. Kassem, H. Sabry, Reem ElMessiery, N. Soliman","doi":"10.21608/ejmm.2023.291146","DOIUrl":"https://doi.org/10.21608/ejmm.2023.291146","url":null,"abstract":"","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"517 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77147207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Candidaemia in Neonatal Intensive Care Units (NICU) at Beni-Suef Governorate 贝尼苏韦夫省新生儿重症监护病房(NICU)中的念珠菌血症
Pub Date : 2023-04-01 DOI: 10.21608/ejmm.2023.293577
{"title":"Candidaemia in Neonatal Intensive Care Units (NICU) at Beni-Suef Governorate","authors":"","doi":"10.21608/ejmm.2023.293577","DOIUrl":"https://doi.org/10.21608/ejmm.2023.293577","url":null,"abstract":"","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80713011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Molecular Mechanisms of Fosfomycin Resistance in MDR Escherichia coli Isolates from Urinary Tract Infections 尿路感染耐多药大肠杆菌对磷霉素耐药的分子机制
Pub Date : 2023-04-01 DOI: 10.21608/ejmm.2023.279741
Rehab Bahy, Wael Mohamed Abu El-Wafa, A. Abouwarda
ABSTRACT
摘要
{"title":"Molecular Mechanisms of Fosfomycin Resistance in MDR Escherichia coli Isolates from Urinary Tract Infections","authors":"Rehab Bahy, Wael Mohamed Abu El-Wafa, A. Abouwarda","doi":"10.21608/ejmm.2023.279741","DOIUrl":"https://doi.org/10.21608/ejmm.2023.279741","url":null,"abstract":"ABSTRACT","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89815752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Can Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio and Tumor Necrosis Factor Alpha Predict Lupus Nephritis Flares? 中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和肿瘤坏死因子α能否预测狼疮性肾炎的发作?
Pub Date : 2023-04-01 DOI: 10.21608/ejmm.2023.281033
S. Fouad, M. Farris, Eman R. Mansour, Mayada Moneer
Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune multisystem disease with an array of variable presentations in which the kidney is the most affected organ and influences the overall outcome of the patients. Methodology: The study is a case control study conducted on 90 SLE patients diagnosed according to ACR criteria grouped into three subgroups. It aims at evaluating the role of serum tumor necrosis factor alpha (TNFα), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in diagnosing renal flares and predicting the prognosis in lupus nephritis patients. Results: A highly significant difference was observed between both the SLE starting dialysis group, the SLE nephritis ( LN ) group, and the control group regarding neutrophil to lymphocyte ratio and TNFα (p<0.001 & ˂ 0.001, respectively). The median serum Neutrophil/Lymphocyte and TNFα were statistically significantly higher in the SLE starting dialysis patient group than the LN patients and the control group. A cut-off value of ≤ 200 for serum TNFα level and of ≤ 4.8 for Neutrophil/lymphocyte ratio sufficiently differentiated between the LN patients and the SLE patients starting dialysis. TNFα cut-off value showed sensitivity of 76.67%, specificity of 96.67%, positive predictive value of 95.8% and negative predictive value of 80.6 %. Neutrophil/Lymphocyte cut-off showed sensitivity of 70.00%, specificity of 70.00%, positive predictive value of 70.00% and negative predictive value of 70.00 %. Conclusion: NLR and TNFα serum levels appear to be useful biomarkers for disease flares and tissue injury in LN patients. Both can identify disease activities, relapses and remissions in lupus nephritis patients.
背景:系统性红斑狼疮(SLE)是一种慢性自身免疫性多系统疾病,具有一系列不同的表现,其中肾脏是受影响最大的器官,影响患者的整体预后。方法:本研究为病例对照研究,将90例符合ACR标准的SLE患者分为3个亚组。目的探讨血清肿瘤坏死因子α (TNFα)、中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)在狼疮性肾炎患者肾脏病变诊断及预后预测中的作用。结果:在SLE开始透析组、SLE肾炎(LN)组和对照组之间,中性粒细胞与淋巴细胞比值和TNFα有高度显著性差异(p<0.001和小于0.001)。SLE开始透析患者组中位血清中性粒细胞/淋巴细胞和TNFα高于LN患者和对照组,具有统计学意义。LN患者与开始透析的SLE患者的血清TNFα水平临界值≤200,中性粒细胞/淋巴细胞比值临界值≤4.8。TNFα截断值敏感性为76.67%,特异性为96.67%,阳性预测值为95.8%,阴性预测值为80.6%。中性粒细胞/淋巴细胞切断的敏感性为70.00%,特异性为70.00%,阳性预测值为70.00%,阴性预测值为70.00%。结论:NLR和TNFα血清水平似乎是LN患者疾病发作和组织损伤的有用生物标志物。两者都可以识别狼疮性肾炎患者的疾病活动、复发和缓解。
{"title":"Can Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio and Tumor Necrosis Factor Alpha Predict Lupus Nephritis Flares?","authors":"S. Fouad, M. Farris, Eman R. Mansour, Mayada Moneer","doi":"10.21608/ejmm.2023.281033","DOIUrl":"https://doi.org/10.21608/ejmm.2023.281033","url":null,"abstract":"Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune multisystem disease with an array of variable presentations in which the kidney is the most affected organ and influences the overall outcome of the patients. Methodology: The study is a case control study conducted on 90 SLE patients diagnosed according to ACR criteria grouped into three subgroups. It aims at evaluating the role of serum tumor necrosis factor alpha (TNFα), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in diagnosing renal flares and predicting the prognosis in lupus nephritis patients. Results: A highly significant difference was observed between both the SLE starting dialysis group, the SLE nephritis ( LN ) group, and the control group regarding neutrophil to lymphocyte ratio and TNFα (p<0.001 & ˂ 0.001, respectively). The median serum Neutrophil/Lymphocyte and TNFα were statistically significantly higher in the SLE starting dialysis patient group than the LN patients and the control group. A cut-off value of ≤ 200 for serum TNFα level and of ≤ 4.8 for Neutrophil/lymphocyte ratio sufficiently differentiated between the LN patients and the SLE patients starting dialysis. TNFα cut-off value showed sensitivity of 76.67%, specificity of 96.67%, positive predictive value of 95.8% and negative predictive value of 80.6 %. Neutrophil/Lymphocyte cut-off showed sensitivity of 70.00%, specificity of 70.00%, positive predictive value of 70.00% and negative predictive value of 70.00 %. Conclusion: NLR and TNFα serum levels appear to be useful biomarkers for disease flares and tissue injury in LN patients. Both can identify disease activities, relapses and remissions in lupus nephritis patients.","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"12 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79485764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IL-23 Receptor Expression on T Helper 17 Cells and its Implication in Multiple Sclerosis Relapse IL-23受体在T辅助17细胞中的表达及其与多发性硬化复发的关系
Pub Date : 2023-04-01 DOI: 10.21608/ejmm.2023.280275
R. Khalifa, Nesma Abdel Aziz, A. Shalash, M. Nada, Shimaa A. Abdel Salam
ABSTRACT
摘要
{"title":"IL-23 Receptor Expression on T Helper 17 Cells and its Implication in Multiple Sclerosis Relapse","authors":"R. Khalifa, Nesma Abdel Aziz, A. Shalash, M. Nada, Shimaa A. Abdel Salam","doi":"10.21608/ejmm.2023.280275","DOIUrl":"https://doi.org/10.21608/ejmm.2023.280275","url":null,"abstract":"ABSTRACT","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84327897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relation between Antibiotic Resistance pattern and the Risk Factors Associated with Urinary Tract Infections Caused by E. coli. 大肠杆菌尿路感染的抗生素耐药模式与危险因素的关系
Pub Date : 2023-04-01 DOI: 10.21608/ejmm.2023.285582
Ahmed G. Merdash, G. El-Sherbiny, A. Elgendy, M. Ahmad, H. El-Kabbany
Background: Urinary tract infections (UTIs) are one of the most common bacterial infections which affect more than 150 million individuals each year worldwide. Objective : this study was conducted to assess the risk factors associated with urinary tract infections (UTIs) caused by resistant Escherichia coli. Methodology Four hundred and thirty urine samples were collected from outpatients who had urinary tract symptoms, ages ranging from 10 to 75 years in Beni-Suef Egypt, during a period extended from January 2021 to the end January 2022 and processed by standard microbiological methods. Results A total of 430 patients were included in this study: 210 (48.82%) uncomplicated and 220 (51.15%) complicated UTIs. Of 430 UTIs patients 287(66.8%) were females (77(36.6%) were complicated and 210(100%) were uncomplicated), while 143 male UTIs patients were classified as complicated (65%). The prevalence of pathogenic microbes reveals bacterial species predominate in UTIs with 376 (87.42%) E. coli high-frequency bacterial strains 85 (19.9%), followed by Klebsiella sp. 70 (16.3), Pseudomonas aeruginosa 58 (13.5%) and Enterococcus sp. 58 (13.5%). Proteus mirabilis 46(10.9%). Among 85 E coli isolates 46 from complicated and 39 isolates from uncomplicated UTIs patients showed the highest resistance to piperacillin/tazobactam 35(41.2%), sulfamethoxazole /trimethoprim 35 (41.2%), amoxicillin-clavulanic acid 34 (40%) and cefepime 34 (40%) and the least resistant antibiotics in the present study were colistin (3.5%), imipenem (5%), quinolones (5%) and nitrofurantoin (5%). Conclusion , nitrofurantoin, and quinoline remain still the best choice for treating complicated and uncomplicated UTI. Risk increases with the number of patients hospitalizations.
背景:尿路感染(uti)是最常见的细菌感染之一,每年影响全球超过1.5亿人。目的:探讨耐药大肠杆菌引起尿路感染的相关危险因素。方法从2021年1月至2022年1月底,从埃及Beni-Suef地区有尿路症状的门诊患者中收集了430份尿液样本,年龄从10岁到75岁不等,并采用标准微生物学方法进行处理。结果本研究共纳入430例患者,其中不合并尿路感染210例(48.82%),合并尿路感染220例(51.15%)。430例尿路感染患者中,女性287例(66.8%),其中合并77例(36.6%),不合并210例(100%),男性合并143例(65%)。病原菌分布情况显示,UTIs病原菌种类最多,大肠杆菌85高频菌株376株(87.42%),占19.9%,其次为克雷伯菌70(16.3)、铜绿假单胞菌58(13.5%)和肠球菌58(13.5%)。奇迹普罗透斯46(10.9%)。85株大肠杆菌中,46株来自复杂型尿路感染患者,39株来自非复杂型尿路感染患者,其中对哌拉西林/他唑巴坦35(41.2%)、磺胺甲新唑/甲氧苄啶35(41.2%)、阿莫西林-克拉维酸34(40%)和头孢吡肟34(40%)的耐药性最高,对粘菌素(3.5%)、亚胺培南(5%)、喹诺酮类药物(5%)和呋喃妥因(5%)的耐药性最低。结论呋喃妥因联合喹啉仍是治疗复杂和非复杂UTI的最佳选择。风险随着住院患者人数的增加而增加。
{"title":"The Relation between Antibiotic Resistance pattern and the Risk Factors Associated with Urinary Tract Infections Caused by E. coli.","authors":"Ahmed G. Merdash, G. El-Sherbiny, A. Elgendy, M. Ahmad, H. El-Kabbany","doi":"10.21608/ejmm.2023.285582","DOIUrl":"https://doi.org/10.21608/ejmm.2023.285582","url":null,"abstract":"Background: Urinary tract infections (UTIs) are one of the most common bacterial infections which affect more than 150 million individuals each year worldwide. Objective : this study was conducted to assess the risk factors associated with urinary tract infections (UTIs) caused by resistant Escherichia coli. Methodology Four hundred and thirty urine samples were collected from outpatients who had urinary tract symptoms, ages ranging from 10 to 75 years in Beni-Suef Egypt, during a period extended from January 2021 to the end January 2022 and processed by standard microbiological methods. Results A total of 430 patients were included in this study: 210 (48.82%) uncomplicated and 220 (51.15%) complicated UTIs. Of 430 UTIs patients 287(66.8%) were females (77(36.6%) were complicated and 210(100%) were uncomplicated), while 143 male UTIs patients were classified as complicated (65%). The prevalence of pathogenic microbes reveals bacterial species predominate in UTIs with 376 (87.42%) E. coli high-frequency bacterial strains 85 (19.9%), followed by Klebsiella sp. 70 (16.3), Pseudomonas aeruginosa 58 (13.5%) and Enterococcus sp. 58 (13.5%). Proteus mirabilis 46(10.9%). Among 85 E coli isolates 46 from complicated and 39 isolates from uncomplicated UTIs patients showed the highest resistance to piperacillin/tazobactam 35(41.2%), sulfamethoxazole /trimethoprim 35 (41.2%), amoxicillin-clavulanic acid 34 (40%) and cefepime 34 (40%) and the least resistant antibiotics in the present study were colistin (3.5%), imipenem (5%), quinolones (5%) and nitrofurantoin (5%). Conclusion , nitrofurantoin, and quinoline remain still the best choice for treating complicated and uncomplicated UTI. Risk increases with the number of patients hospitalizations.","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78236075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Enteric Pathogens in the Prepackaged Salads in Makkah City, Saudi Arabia 沙特阿拉伯麦加市预包装沙拉中肠道病原体的流行情况
Pub Date : 2023-04-01 DOI: 10.21608/ejmm.2023.287944
Sami S. Ashgar, Bashair Alharthi, Hamdi M. Al-Said, Naif A. Jalal, A. Momenah, A. Barhameen, S. Hariri, Farkad Bantun, E. Khidir, Asim Abdulshakoor, Batool J Alghamdi, Rahf Albarakati
{"title":"Prevalence of Enteric Pathogens in the Prepackaged Salads in Makkah City, Saudi Arabia","authors":"Sami S. Ashgar, Bashair Alharthi, Hamdi M. Al-Said, Naif A. Jalal, A. Momenah, A. Barhameen, S. Hariri, Farkad Bantun, E. Khidir, Asim Abdulshakoor, Batool J Alghamdi, Rahf Albarakati","doi":"10.21608/ejmm.2023.287944","DOIUrl":"https://doi.org/10.21608/ejmm.2023.287944","url":null,"abstract":"","PeriodicalId":22549,"journal":{"name":"The Egyptian Journal of Medical Microbiology","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79088479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Egyptian Journal of Medical Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1